1.
Lio P, Kim Y, Balu S, Costantino H, Bates D, Rene C, Lopez A, Soung J. Tralokinumab Real-World Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis Adult Patients in the United States: 6-Month Interim Analysis. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s318. Available from: https://jofskin.org/33014/index.php/skin/article/view/2399